Pfizer UK appoints new MD
This article was originally published in Scrip
Executive Summary
Erik Nordkamp has been appointed managing director and head of Global Innovative Pharmaceutical business at Pfizer UK, taking over from Jonathan Emms who has been appointed global marketing lead for Pfizer's Global Established Pharmaceutical business. Mr Nordkamp joined Pfizer in 2010 and for the past year has led the firm's Greece, Cyprus and Malta, and the Global Innovative Pharmaceutical business. Prior to this, he worked for Pfizer in the UK as head of strategy for Primary Care Europe and Canada. Erik also served as president of PhRMA Innovation, a trade association, where he led the transformation of the forum, positioning it as the main representative body for the innovative pharmaceutical industry in Greece.
You may also be interested in...
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.
Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease
Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity.
Deals Of The Year 2023 Winners Revealed
For In Vivo's 16th annual Deals of the Year contest, we selected 12 nominees in three categories – Top Alliance, Top Financing and Top M&A. The polls are closed, and it is time to reveal the winners.